The most common method of controlling acidemia during lung-protective ventilation is CO₂ removal with an extracorporeal lung assist (ECLA) system. Another possibility to prevent acidemia is based on intravenous (i.v.) application of tris-hydroxymethyl-aminomethane (3 mol/L, THAM) buffer, which can bind hydrogen protons and which can be removed from the body via renal replacement therapy (RRT). We investigated whether RRT combined with predilutional (prefilter) THAM-application provides an alternative to ECLA for a rescue situation. For this, anesthetized pigs, 40 kg of body weight, six animals per group, underwent 5 h of acidemia (pH 7.19-7.24) induced by acid infusion and permissive hypercapnia (low tidal volume ventilation, PaCO₂ 80-90 mmHg). Isovolemic, high-volume hemofiltration (HVHF) was operated with predilutional THAM-infusion for treatment. To evaluate adverse effects of this approach, we set up further groups: HVHF with postdilutional (post-filter) THAM-application; i.v.-THAM without HVHF; normal pH homeostasis with HVHF. Acid-base parameters, hemodynamics, renal function, and lung morphology were investigated. HVHF with predilutional THAM-infusion of 8 mmol/kg/h allowed fast pH normalization, significant reduction in PaCO₂ to 56 mmHg and tolerable hemodynamics. HVHF alone or lower dose i.v. THAM (2 mmol/kg/h) failed to produce a comparable result. A postdilutional THAM infusion reduced hemodynamic tolerability and increased lung edema formation. HVHF in pigs with normal acid-base status resulted in a decreased base excess and urine acidification. In conclusion, predilutional THAM-application and HVHF corrected the acid-base disorder and improved pulmonary hemodynamics. Further studies are necessary to optimize the protocol including the dosage.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1594.2011.01204.xDOI Listing

Publication Analysis

Top Keywords

high-volume hemofiltration
8
low tidal
8
tidal volume
8
hvhf
8
predilutional tham-infusion
8
predilutional
5
experimental high-volume
4
hemofiltration predilutional
4
predilutional tris-hydroxymethylaminomethane
4
tris-hydroxymethylaminomethane correction
4

Similar Publications

Real-world effectiveness of hemodialysis modalities: a retrospective cohort study.

BMC Nephrol

January 2025

Fresenius Medical Care Deutschland GmbH, Bad Homburg, Hessen, Germany.

Background: Results from the CONVINCE clinical trial suggest a 23% mortality risk reduction among patients receiving high-volume (> 23 L) hemodiafiltration. We assessed the real-world effectiveness of blood-based kidney replacement therapy (KRT) with hemodiafiltration vs. hemodialysis in a large, unselected patient population treated prior to and during the COVID-19 pandemic.

View Article and Find Full Text PDF

Various high-efficiency hemodialysis techniques exist, including different online high- volume hemodiafiltration (HDF) modes and expanded hemodialysis (HDx) utilizing dialyzers with medium cut-off (MCO) membranes. This study aimed to evaluate the efficacy of uremic toxin removal among four modalities: (I) HDx, (II) pre-dilution HDF (PRE-HDF), (III) mixed-dilution HDF (MIX-HDF), and (IV) post-dilution HDF (POST-HDF), each applied for 1 week in a randomized order. This research was a single-center, prospective, open-label, exploratory crossover study.

View Article and Find Full Text PDF

The Donnan equilibrium is still valid in high-volume HDF.

Int J Artif Organs

December 2024

Global Systems Engineering, VS Machines, Care Enablement, Fresenius Medical Care Deutschland GmbH, Schweinfurt, Bavaria, Germany.

Clinical studies have shown that hemodiafiltration reduces morbidity and mortality of dialysis patients compared to hemodialysis alone. This is attributed to its superior middle molecule clearance compared to standard hemodialysis. However, doubts arose as to whether a high convective flux through the dialyzer membrane has an influence on the equilibrium concentration of small ions, especially that of sodium.

View Article and Find Full Text PDF

Dialysis modality and quality of life: more answers yet more questions.

Kidney Int

November 2024

Division of Nephrology, Department of Medicine, University of California Davis Health, Sacramento, California, USA.

Persons with end-stage kidney disease treated with dialysis experience distressing reductions in quality of life and increased mortality. Few large, randomized trials in nephrology have reported on health-related quality of life. Rose et al.

View Article and Find Full Text PDF

[Extracorporeal procedures in sepsis].

Anaesthesiologie

October 2024

Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen, Eberhard-Karls-Universität Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.

Article Synopsis
  • Sepsis and septic shock are serious conditions linked to infections and can lead to high mortality rates; this article reviews extracorporeal procedures for their treatment.
  • Various treatments like HVHF, VHVHF, HCO, and Polymyxin B hemoperfusion aim to remove inflammatory substances but lack clear evidence for improving patient survival.
  • Despite showing promise in initial studies, risks such as thrombosis and protein loss remain, and further research is needed to establish the safety and efficacy of these treatments for sepsis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!